GlassScriptPhysician profile
Marc J Guttman
NPI 1972708154
$17,755.48
in general payments reported to CMS, 2019-2025
47 companies · $1,909 in 2025
The $1,909 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,734 · 2020: $4,265 · 2021: $1,458 · 2022: $2,636 · 2023: $2,610 · 2024: $2,143 · 2025: $1,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,662.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $3,060.24 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $3,008.68 | 2019-2024 | Myrbetriq |
| Neotract INC. | $2,058.16 | 2019-2020 | |
| Axonics, INC. | $1,379.52 | 2020-2024 | Axonics |
| Janssen Biotech, INC. | $1,264.37 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $904.54 | 2020-2024 | |
| Urogen Pharma, INC. | $858.12 | 2020-2025 | Jelmyto |
| Coloplast Corp | $710.59 | 2019-2025 | Self-Cath, Speedicath |
| Boston Scientific Corporation | $524.95 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System, Axonics |
| Procept Biorobotics Corporation | $474.20 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Sumitomo Pharma America, INC. | $397.32 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $313.03 | 2019-2023 | Aveed, Xiaflex, Edex |
| Abbvie INC. | $271.77 | 2022-2025 | |
| Immunitybio, INC. | $209.10 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $179.60 | 2019-2025 | Adstiladrin, Firmagon |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $173.61 | 2019-2024 | |
| Allergan, INC. | $145.15 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $133.51 | 2025 | Balversa, Akeega, Erleada |
| Dendreon Pharmaceuticals LLC | $133.35 | 2019-2025 | Provenge |
| Genzyme Corporation | $125.00 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $108.37 | 2020-2022 | |
| Srs Medical Systems, INC. | $102.92 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Tolmar, INC. | $100.71 | 2023-2025 | Eligard, Jatenzo |
| Antares Pharma, INC. | $100.34 | 2019-2023 | Xyosted, Nocdurna, Tlando |
| Urovant Sciences INC | $80.05 | 2022 | |
| Laborie Medical Technologies Corp. | $66.56 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Intrinsiq Specialty Solutions, INC. | $65.99 | 2024 | |
| Rochester Medical Corporation | $63.87 | 2019 | |
| Olympus America INC. | $63.62 | 2022-2023 | Itind System |
| Baudax Bio INC. | $62.52 | 2020-2021 | |
| Acerus Pharmaceuticals Corporation | $62.39 | 2020-2021 | |
| Mission Pharmacal Company | $55.94 | 2023-2024 | Uribel, Uribel Tabs |
| Metuchen Pharmaceuticals | $54.27 | 2019-2020 | |
| Valencia Technologies Corporation | $50.13 | 2023 | Ecoin Device Kit |
| Myovant Sciences INC. | $49.32 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $48.43 | 2019 | |
| Amgen INC. | $36.54 | 2019 | |
| Myriad Genetic Laboratories, INC. | $35.74 | 2024 | Prolaris |
| Ambu INC. | $33.01 | 2022-2025 | |
| Arthrex, INC. | $31.26 | 2024 | Arthrex |
| Pfizer INC. | $27.47 | 2025 | |
| Abbott Laboratories | $25.04 | 2022 | |
| Civco Medical Instruments | $23.37 | 2025 | |
| Sun Pharmaceutical Industries INC. | $22.67 | 2024 | |
| Telix Pharmaceuticals | $22.28 | 2024 | Illuccix |
| Novartis Pharmaceuticals Corporation | $22.23 | 2023 | |
| Angiodynamics, INC. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Guttman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.